Skip to main content
search

Dr. Leigh Turner awarded grant to study ethics of using biocomputing to build neural networks

By September 10, 2024Carousel Slider, In the News

Dr. Leigh Turner, Professor of Health, Society and Behavior, School of Public Health

As part of a collaborative project with USC and other faculty at UCI, Dr. Leigh Turner has been awarded a 2 million dollar grant from National Science Foundation to use biocomputing and stem cells to build neural networks to one day combat neurodegenerative diseases. Dr. Turner’s role will be to study the ethical implications of this potential technology.  Read the article in UCI News.

Related posts:

  1. New Alzheimer’s drugs bring hope. But not equally for all patients. The medications have not been widely tested in Black people with the disease, underscoring stark — and persistent — disparities ABINGTON, Pa. — Wrapped in a purple blanket, Robert Williford settles into a quiet corner of a bustling neurology clinic, an IV line delivering a colorless liquid into his left...
  2. FDA Approves Donanemab Today, the US Food and Drug Administration granted full clinical approval to Eli Lilly to market donanemab, brand name KISUNLA, for the treatment of early Alzheimer’s disease, including Mild Cognitive Impairment (MCI) or mild dementia. Donanemab is a monoclonal antibody against the beta-amyloid protein that accumulates in the brain of...
  3. Dr. Vivek Swarup quoted in AlzForum about newly identified risk genes Dr. Vivek Swarup, associate professor of Neurobiology and Behavior and UCI MIND faculty member, was quoted this week in the popular online Alzheimer’s disease publication, AlzForum, regarding 4 new AD risk genes that have been identified.  ...
Close Menu